Reckitt Benckiser

Reckitt Benckiser is a British multinational consumer goods company that manufactures and markets products in the health, hygiene and home categories. Its portfolio includes well‑known brands such as Dettol, Lysol, Finish, Vanish, Nurofen and Strepsil, which are sold through retail channels in numerous countries. The company focuses on developing formulations that address personal cleanliness, disease prevention and household maintenance, serving both individual consumers and institutional buyers across diverse markets.

Headquartered in Slough, United Kingdom, Reckitt Benckiser operates in more than sixty nations and distributes its goods to roughly one hundred and eighty countries worldwide. It is a publicly listed entity on the London Stock Exchange, forming part of the FTSE 100 index, and reports annual revenues that place it among the leading global consumer goods firms. The 2017 NotPetya cyberattack disrupted its manufacturing and distribution networks, leading to a revised sales forecast reduction of about $130 million and highlighting the vulnerability of its supply chain to sophisticated digital threats.

Reckitt Benckiser distinguishes itself through a strong emphasis on research and development, investing heavily in innovation to introduce new product lines and improve existing formulations. Its competitive advantage lies in the breadth of its trusted brands and its ability to respond quickly to public health trends, such as increased demand for disinfectants during disease outbreaks. Structurally, the company maintains a number of subsidiaries, including the acquisition of Mead Johnson Nutrition in 2017, which expanded its presence in the infant nutrition segment. Reckitt Benckiser remains governed by a unitary board structure typical of UK‑listed public limited companies, with shareholders exercising voting rights through ordinary shares.